Tag archive for ‘NasVax Ltd. (TASE: NSVX)’
Gali Weinreb On Monday, February 17th, 2014

GSK And Technion Sign Drug Development Deal

– GlaxoSmithKline and BioRap will commercialize a treatment for lethal side effects of bone marrow transplants. – – Pharmaceutical giant GlaxoSmithKline plc (LSE: GSK) has signed a joint More...

Globes On Sunday, June 30th, 2013

Chinese Pharmaceutical company Acebright invests in Israeli NasVax

– Pharmaceutical company Acebright will invest $1 million for a 10% stake in NasVax. – – / By Hillel Koren / NasVax Ltd. (TASE: NSVX), a developer of innovative immunotherapeutics, has More...

Wordpress site Developed by Fixing WordPress Problems